Exploration of the 5-bromopyrimidin-4(3H)-ones as potent inhibitors of PDE5

Bioorg Med Chem Lett. 2013 Sep 1;23(17):4944-7. doi: 10.1016/j.bmcl.2013.06.062. Epub 2013 Jun 29.

Abstract

The substituents both at the 6-position of the 5-bromopyrimidinone ring and at the 5'-position of the phenyl ring of 5-bromopyrimidin-4(3H)-ones were explored. 5-Bromo-6-isopropyl-2-(2-propoxy-phenyl)pyrimidin-4(3H)-one was identified as a new scaffold for potent PDE5 inhibitors. The crystal structures of PDE5/2e and PDE5/10a complexes provided a structural basis for the inhibition of 5-bromopyrimidinones to PDE5. In addition, it was also found that there is a great tolerance for the substitution at the 5'-position of the phenyl ring of 5-bormopyrimidinones and the resulted compound 13a has the highest inhibition activity to PDE5 (IC50, 1.7 nM).

Keywords: 5-Bromopyrimidin-4(3H)-ones; PDE5 inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclic Nucleotide Phosphodiesterases, Type 5 / chemistry
  • Cyclic Nucleotide Phosphodiesterases, Type 5 / metabolism
  • Halogenation
  • Humans
  • Models, Molecular
  • Phosphodiesterase 5 Inhibitors / chemistry*
  • Phosphodiesterase 5 Inhibitors / pharmacology*
  • Pyrimidines / chemistry*
  • Pyrimidines / pharmacology*
  • Structure-Activity Relationship

Substances

  • Phosphodiesterase 5 Inhibitors
  • Pyrimidines
  • Cyclic Nucleotide Phosphodiesterases, Type 5